Fluvac Innovator EHV-4/1 (Canada)

Company: Zoetis

Equine Rhinopneumonitis-Influenza Vaccine

Killed Virus

This product has been shown to be effective for the vaccination of healthy horses 10 months of age or older against equine rhinopneumonitis caused by type 1 and 4 viruses and equine influenza caused by type A2. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Fluvac Innovator EHV-4/1 contains equine influenza virus A/equine-2/Kentucky/97 (H3N8)-American Lineage.

Field safety testing has demonstrated that this product is safe for use in horses 3 months of age or older. Efficacy has not been established in foals 3 months of age.

Efficacy has been demonstrated in 10-month-old horses by challenge with equine influenza virus A/equine-2/Ohio/03 (H3N8)-American Lineage.

Directions For Use

Shake well. Aseptically administer 1 mL intramuscularly. Healthy horses should receive two doses administered 3-4 weeks apart. For advice on revaccination frequency or in the face of stress or exposure, contact your veterinarian or the manufacturer.

Precautions

Store at 2°-8°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze. Transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. Contains formalin, thimerosal, neomycin, and polymyxin B as preservatives. This product has not been tested on pregnant animals. Do not mix with other products. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Canada Inc. Veterinary Services, (800) 461-0917.

For veterinary use only

Remove serial number and expiration date label and place on the animal’s medical chart.

VLN 190/PCN 1515.27

Zoetis Inc., Kalamazoo, MI 49007, USA

August 2024

CPN: 1198424.3